search
Back to results

EnSeal Device Versus Ferguson Technique in Hemorrhoidectomy

Primary Purpose

Hemorrhoids

Status
Unknown status
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
EnSeal Device
Ferguson Hemorrhoidectomy technique
Sponsored by
Steven Schechter, M.D.
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Hemorrhoids focused on measuring Hemorrhoidectomy, Hemorrhoids

Eligibility Criteria

18 Years - 80 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  1. Men & woman between ages 18-80.
  2. ASA level I, II, and III.
  3. External hemorrhoids may or may not be present.
  4. Internal hemorrhoids at least Grade II, III, and IV.

Exclusion Criteria:

  1. Age less than 18, or greater than 80.
  2. ASA level IV.
  3. Grade I internal hemorrhoids.
  4. Patients on Coumadin, Plavix, or other anticoagulant.
  5. Associated procedure such as sphincterotomy, drainage of abscess, fistulotomy, or the like.
  6. Pregnancy - Women who have a positive urine pregnancy test pre-op will be excluded from the study.
  7. Inflammatory bowel disease.
  8. History of chronic active hepatitis B, C, or HIV infection.
  9. Lactating women.
  10. Inability to follow up with surgeon in office at 1 week, 4 weeks, and 3 months postoperatively.
  11. Prior chronic narcotic use (> 30 days)

Sites / Locations

  • The Miriam Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

1. EnSeal Device

2. Ferguson Hemorrhoidectomy

Arm Description

The EnSeal device cuts and seals with heat energy leaving a sutureless wound, which heals with security against bleeding. The device is able to seal blood vessels up to 7mm and hemorrhoidal vessels are much smaller than this size.

The closed Ferguson hemorrhoidectomy technique is a gold standard operation that has been in existence for 50 years. This operation is done under general or intravenous sedation, and the operating surgeon uses a special clamp to go across the hemorrhoidal complex followed by excision of the hemorrhoid. Sutures that dissolve are then placed at the root of the hemorrhoid, securely tied, and then run about the clamp. The clamp is removed and then the suture tightened, then the suture line is reinforced.

Outcomes

Primary Outcome Measures

to examine the advantage and disadvantages of the EnSeal device as it applies to hemorrhoidal surgery and document outcomes as compared to the traditional closed Ferguson hemorrhoidectomy

Secondary Outcome Measures

Full Information

First Posted
February 27, 2009
Last Updated
November 19, 2012
Sponsor
Steven Schechter, M.D.
Collaborators
Ethicon, Inc.
search

1. Study Identification

Unique Protocol Identification Number
NCT00853853
Brief Title
EnSeal Device Versus Ferguson Technique in Hemorrhoidectomy
Official Title
Randomized Trial Comparing Standard Ferguson Technique With the EnSeal Device During Hemorrhoidectomy
Study Type
Interventional

2. Study Status

Record Verification Date
November 2012
Overall Recruitment Status
Unknown status
Study Start Date
March 2009 (undefined)
Primary Completion Date
December 2012 (Anticipated)
Study Completion Date
December 2012 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Steven Schechter, M.D.
Collaborators
Ethicon, Inc.

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
This study will compare hemorrhoid surgery by comparing a sutureless heating device with the old standard hemorrhoid surgery. Patients will be followed closely for wound healing and satisfaction. Hypothesis: The sutureless device will be less painful for the patient and easier for the surgeon to perform.
Detailed Description
The EnSeal Device is approved for laparoscopic surgery in ligating and dividing vascular tissue during abdominal surgery. Electrical energy is converted into heat energy and resultant simultaneous division of tissues. This allows surgery to be bloodless and sutureless. This device is being used in the current study in the treatment of hemorrhoidal disease where vascular tissue is excised in bloodless and sutureless fashion. The device is FDA-approved for laparoscopic surgery. This is currently being used in institutions throughout the United States and Europe. This study is looking at the EnSeal device and comparing it to a gold standard hemorrhoidal procedure to see if the OR procedure can be simplified and the postoperative course improved. The trial is a randomized, controlled, prospective study. Patients will be informed of the two techniques being studied and will be randomized in the operating room by opening up an envelope with the procedure to be employed inside. The envelopes will be numbered 1 through 100, with 50 envelopes containing a slip of paper stating that the surgery will be done using the Ferguson technique and 50 envelopes containing a slip of paper stating the that the surgery will be done using the EnSeal device. These slips of paper will be placed in the envelopes and sealed. The envelopes will be mixed up by someone not involved in the study and then numbered 1 through 100. No one will know which surgical technique will be used on the patient until the surgeon opens the envelope on the day of surgery. Patients will be followed postoperatively in the office during week 1, week 4, and week 12. At this time, they will be assessed for postoperative complications including but not limited to: bleeding, urinary retention, infection, fecal impaction, hospital re-admission and pain. Delayed complications will also be followed including urinary retention, impaired healing, constipation, abscess, fistula formation, fissure, stenosis, fecal incontinence, and flatus incontinence. The patient's pain score will be assessed using the Universal Pain Assessment Tool, allowing the patient to describe their pain level on a scale between 1 and 10.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hemorrhoids
Keywords
Hemorrhoidectomy, Hemorrhoids

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
100 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
1. EnSeal Device
Arm Type
Active Comparator
Arm Description
The EnSeal device cuts and seals with heat energy leaving a sutureless wound, which heals with security against bleeding. The device is able to seal blood vessels up to 7mm and hemorrhoidal vessels are much smaller than this size.
Arm Title
2. Ferguson Hemorrhoidectomy
Arm Type
Active Comparator
Arm Description
The closed Ferguson hemorrhoidectomy technique is a gold standard operation that has been in existence for 50 years. This operation is done under general or intravenous sedation, and the operating surgeon uses a special clamp to go across the hemorrhoidal complex followed by excision of the hemorrhoid. Sutures that dissolve are then placed at the root of the hemorrhoid, securely tied, and then run about the clamp. The clamp is removed and then the suture tightened, then the suture line is reinforced.
Intervention Type
Device
Intervention Name(s)
EnSeal Device
Intervention Description
Hemorrhoidectomy using the EnSeal Device, which is an instrument cuts and seals with heat energy leaving a sutureless wound, which heals with security against bleeding.
Intervention Type
Procedure
Intervention Name(s)
Ferguson Hemorrhoidectomy technique
Intervention Description
The closed Ferguson hemorrhoidectomy technique is a gold standard operation that has been in existence for 50 years. This operation is done under general or intravenous sedation, and the operating surgeon uses a special clamp to go across the hemorrhoidal complex followed by excision of the hemorrhoid. Sutures that dissolve (such as 3.0 vicryl) are then placed at the root of the hemorrhoid, securely tied, and then run about the clamp. The clamp is removed and then the suture tightened, then the suture line is reinforced. This can be done from 1-3 hemorrhoidal groups at a single time.
Primary Outcome Measure Information:
Title
to examine the advantage and disadvantages of the EnSeal device as it applies to hemorrhoidal surgery and document outcomes as compared to the traditional closed Ferguson hemorrhoidectomy
Time Frame
1 week, 4 weeks and 12 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Men & woman between ages 18-80. ASA level I, II, and III. External hemorrhoids may or may not be present. Internal hemorrhoids at least Grade II, III, and IV. Exclusion Criteria: Age less than 18, or greater than 80. ASA level IV. Grade I internal hemorrhoids. Patients on Coumadin, Plavix, or other anticoagulant. Associated procedure such as sphincterotomy, drainage of abscess, fistulotomy, or the like. Pregnancy - Women who have a positive urine pregnancy test pre-op will be excluded from the study. Inflammatory bowel disease. History of chronic active hepatitis B, C, or HIV infection. Lactating women. Inability to follow up with surgeon in office at 1 week, 4 weeks, and 3 months postoperatively. Prior chronic narcotic use (> 30 days)
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Steven Schechter, MD
Organizational Affiliation
The Miriam Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
The Miriam Hospital
City
Providence
State/Province
Rhode Island
ZIP/Postal Code
02906
Country
United States

12. IPD Sharing Statement

Learn more about this trial

EnSeal Device Versus Ferguson Technique in Hemorrhoidectomy

We'll reach out to this number within 24 hrs